Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
1994 |
| gptkbp:ATCCode |
J05AB09
|
| gptkbp:availableOn |
gptkb:tablet
|
| gptkbp:brand |
gptkb:famciclovir
|
| gptkbp:CASNumber |
104227-87-4
|
| gptkbp:chemicalFormula |
C14H19N5O4
|
| gptkbp:contraindication |
hypersensitivity to famciclovir
|
| gptkbp:eliminationHalfLife |
2-3 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Famvir
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
DNA polymerase inhibitor
|
| gptkbp:metabolism |
gptkb:penciclovir
|
| gptkbp:pregnancyCategory |
B (US)
B1 (Australia) |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea fatigue headache |
| gptkbp:usedFor |
gptkb:herpes_simplex_virus
genital herpes herpes zoster cold sores |
| gptkbp:bfsParent |
gptkb:famciclovir
|
| gptkbp:bfsLayer |
6
|